Stock Price Quote

IOL CHEMICALS AND PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE363.002.6 (+0.72 %)
PREV CLOSE ( ) 360.40
OPEN PRICE ( ) 361.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 40621
TODAY'S LOW / HIGH ( )360.90 376.85
52 WK LOW / HIGH ( )272.2 535.6
NSE361.450.65 (+0.18 %)
PREV CLOSE( ) 360.80
OPEN PRICE ( ) 362.00
BID PRICE (QTY) 361.45 (3575)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 697062
TODAY'S LOW / HIGH( ) 361.10 378.00
52 WK LOW / HIGH ( )272.8 535.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1986
Management Info
Rajender Mohan Malla - Chairman Varinder Gupta - Managing Director
Registered Office

Address Village Fatehgarh Channa,Mansa Road, ,
Barnala,
Punjab-148101

Phone 01679-285285-86

Email investor@iolcp.com

Website www.iolcp.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

19Mar IOL Chemicals completes ANVISA GMP aud
IOL Chemicals and Pharmaceuticals has successfully completed the Brazili..
19Mar IOL Chemicals zooms on completing ANVI
IOL Chemicals and Pharmaceuticals is currently trading at Rs. 408.10, up..
19Feb IOL Chemicals gets approval for ‘Metfo
IOL Chemicals and Pharmaceuticals has received approval from Center for..
08Feb IOL Chemicals gains on getting nod to
IOL Chemicals and Pharmaceuticals is currently trading at Rs. 419.95, up..
07Feb IOL Chemicals and Pharmaceuticals repo
IOL Chemicals and Pharmaceuticals (IOL) has reported results for third q..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit232.31399.8
Gross Profit 322.4 1894.9
Operating Profit 528.62520.9
Net Sales 5203.922171.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  8198.15 (3.07%)
M.Cap ( in Cr)18585.71
Dr. Reddy's Lab (BSE)
peergroup  6171.85 (2.05%)
M.Cap ( in Cr)102676.64
Divi's Lab (BSE)
peergroup  3452.55 (2.61%)
M.Cap ( in Cr)91087.58
Caplin Point Lab (BSE)
peergroup  1330.00 (5.56%)
M.Cap ( in Cr)9765.35
RPG Life Sciences (BSE)
peergroup  1530.00 (3.90%)
M.Cap ( in Cr)2524.02

Shareholding Pattern

NON-INSTITUTION 49.27%
PROMOTERS 48.19%
MUTUAL FUNDS/UTI 0.06%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About IOL Chemicals And Pharmaceuticals Ltd.

IOL Chemicals And Pharmaceuticals Ltd. was incorporated in the year 1986. Its today's share price is 363. Its current market capitalisation stands at Rs 2153.32 Cr. In the latest quarter, company has reported Gross Sales of Rs. 22171.1 Cr and Total Income of Rs.22426.8 Cr. The company's management includes Abhay Raj Singh, Sharad Tyagi, Kushal Kumar Rana, Harpal Singh, Sandhya Mehta, Abhiraj Gupta, Vikas Gupta, Varinder Gupta, Rajender Mohan Malla.

It is listed on the BSE with a BSE Code of 524164 , NSE with an NSE Symbol of IOLCP and ISIN of INE485C01011. It's Registered office is at Village Fatehgarh Channa,Mansa Road, Barnala-148101, Punjab. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Ashwani & Associates, SC Vasudeva & Co, SCV & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.